BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36914051)

  • 1. Atrophy, hypometabolism and implication regarding pathology in late-life major depression with suspected non-alzheimer pathophysiology (SNAP).
    Wu KY; Lin KJ; Chen CH; Liu CY; Wu YM; Yen TC; Hsiao IT
    Biomed J; 2023 Dec; 46(6):100589. PubMed ID: 36914051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Cerebral Amyloid-β Depositions in Patients With a Lifetime History of Major Depression With Suspected Non-Alzheimer Pathophysiology.
    Wu KY; Lin KJ; Chen CH; Liu CY; Wu YM; Chen CS; Yen TC; Hsiao IT
    Front Aging Neurosci; 2022; 14():857940. PubMed ID: 35721010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.
    Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL
    JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.
    Mormino EC; Papp KV; Rentz DM; Schultz AP; LaPoint M; Amariglio R; Hanseeuw B; Marshall GA; Hedden T; Johnson KA; Sperling RA
    JAMA Neurol; 2016 Oct; 73(10):1185-1191. PubMed ID: 27548655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
    J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy.
    Wu KY; Lin KJ; Chen CH; Chen CS; Liu CY; Huang SY; Yen TC; Hsiao IT
    Brain Behav; 2018 Jul; 8(7):e01016. PubMed ID: 29927088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.
    Hohman TJ; Dumitrescu L; Oksol A; Wagener M; Gifford KA; Jefferson AL;
    PLoS One; 2017; 12(11):e0188501. PubMed ID: 29190651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
    Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
    JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R;
    Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.
    La Joie R; Perrotin A; Barré L; Hommet C; Mézenge F; Ibazizene M; Camus V; Abbas A; Landeau B; Guilloteau D; de La Sayette V; Eustache F; Desgranges B; Chételat G
    J Neurosci; 2012 Nov; 32(46):16265-73. PubMed ID: 23152610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum.
    Stocks J; Heywood A; Popuri K; Beg MF; Rosen H; Wang L;
    J Alzheimers Dis; 2023; 92(2):513-527. PubMed ID: 36776061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
    Kljajevic V; Grothe MJ; Ewers M; Teipel S;
    Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study.
    Li P; Hsiao IT; Liu CY; Chen CH; Huang SY; Yen TC; Wu KY; Lin KJ
    EJNMMI Res; 2017 Dec; 7(1):24. PubMed ID: 28324341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.
    Chételat G; Ossenkoppele R; Villemagne VL; Perrotin A; Landeau B; Mézenge F; Jagust WJ; Dore V; Miller BL; Egret S; Seeley WW; van der Flier WM; La Joie R; Ames D; van Berckel BN; Scheltens P; Barkhof F; Rowe CC; Masters CL; de La Sayette V; Bouwman F; Rabinovici GD
    Brain; 2016 Sep; 139(Pt 9):2528-39. PubMed ID: 27357349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.